Pharmacoepidemiology and Pharmaceutical Reimbursement Policy

Pharmacoepidemiologic research can have an important impact on the decisions that are made within the realm of formulary reimbursement policy. These decision are often guided by pharmacoeconomic analyses which are used as an implicit measure of a drug product's value in the real world. To ensure the real‐world representativeness of costs and consequences in a pharmacoeconomic analysis, pharmacoepidemiologic data are a necessary supplement in …